Pathogenicity of catalytic antibodies: catalytic activity of Bence Jones proteins from myeloma patients with renal impairment can elicit cytotoxic effects
-
Kinji Matsuura
Abstract
Some Bence Jones proteins (BJPs) can display catalytic activity. Although the catalytic activity of BJPs might be associated with the pathogenesis of disease, this relationship has not yet been established. We tested the effects of seven BJPs on LLC-PK1 cells to assess their pathogenicity. Two out of the seven BJPs showed cytotoxic activity, as assessed by microscopic analysis, the WST method and TUNEL staining. Moreover, the cytotoxic BJPs were excreted by patients who presented with renal impairment. The cytotoxic BJPs displayed 20- to 40-fold higher catalytic activities (kcat of 3.5–2.2 min-1) in hydrolyzing a chromogenic substrate compared to the other BJPs. By treating the cytotoxic BJPs with diisopropylfluorophosphate, they lost not only their catalytic activity, but also the cytotoxic effects. These results indicate a direct link between cytotoxicity and the catalytic activity of the BJPs. The catalytic activity of BJPs contributes to the pathogenesis, as well as to development, of symptoms of multiple myeloma. Inhibition of the catalytic activity of BJPs may form the basis of a novel treatment for multiple myeloma patients with renal dysfunction.
References
Buxbaum, J. (1992). Mechanisms of disease, monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease. Hematol. Oncol. Clin. North Am.6, 323–346.10.1016/S0889-8588(18)30347-2Search in Google Scholar
Dammacco, F. and Waldenstrom, J. (1968). Serum and urine light chain levels in benign monoclonal gammopathies, multiple myeloma and Waldenstrom's macroglobulinaemia. Clin. Exp. Immunol.3, 911–921.Search in Google Scholar
DeFronzo, R.A., Cooke, C.R., Wright, J.R., and Humphrey, R.L. (1978). Renal function in patients with multiple myeloma. Medicine57, 151–166.10.1097/00005792-197803000-00003Search in Google Scholar
Erhan, S. and Greller, L.D. (1974). Do immunoglobulins have proteolytic activity? Nature251, 353–355.10.1038/251353a0Search in Google Scholar
Fang, L.S. (1985). Light-chain nephropathy. Kidney Int.27, 582–592.10.1038/ki.1985.50Search in Google Scholar
Gavrieli, Y., Sherman, Y., and Ben-Sasson, S.A. (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol.119, 493–501.10.1083/jcb.119.3.493Search in Google Scholar
Hatiuchi, K., Hifumi, H., Mitsuda, Y., and Uda, T. (2003). Endopeptidase character of monoclonal antibody i41-7 subunits. Immunol. Lett.86, 249–257.10.1016/S0165-2478(03)00030-0Search in Google Scholar
Hifumi, E., Okamoto, Y., and Uda, T. (2000). How and why 41S-2 antibody subunits acquire the ability to catalyze decomposition of the conserved sequence of gp41 of HIV-1. Appl. Biochem. Biotechnol.83, 209–219.10.1385/ABAB:83:1-3:209Search in Google Scholar
Hifumi, E., Kondo, H., Mutsuda, Y., and Uda, T. (2003). Catalytic features of monoclonal antibody i41SL1-2 subunits. Biotechnol. Bioeng.84, 485–493.10.1002/bit.10806Search in Google Scholar
Kyle, R.A. and Gartz, M.A. (1995). Primary systemic amyloidosis, clinical and laboratory features in 474 cases. Semin. Hematol.32, 45–59.Search in Google Scholar
Li, L., Paul, S., Tyutyulkova, S., Kazatchkine, M.D., and Kaveri, S. (1995). Catalytic activity of anti-thyroglobulin antibodies. J. Immunol.154, 3328–3332.10.4049/jimmunol.154.7.3328Search in Google Scholar
Matsuura, K. and Sinohara, H. (1996). Catalytic cleavage of vasopressin by human Bence Jones proteins at the arginylglycinamide bond. Biol. Chem.377, 587–589.10.1515/bchm3.1996.377.9.587Search in Google Scholar
Matsuura, K., Yamamoto, K., and Sinohara, H. (1994). Amidase activity of human Bence Jones proteins. Biochem. Biophys. Res. Commun.204, 57–62.10.1006/bbrc.1994.2425Search in Google Scholar
Matsuura, K., Ikoma, S., Yoshida, K., and Sinohara, H. (1998). DNA-hydrolyzing activity of Bence Jones proteins. Biochem. Biophys. Res. Commun.243, 719–721.10.1006/bbrc.1998.8164Search in Google Scholar
Matsuura, K., Ikoma, S., Watanabe, M., Togawa, A., and Sinohara, H. (1999). Some Bence-Jones proteins enter cultured renal tubular cells, reach nuclei and induce cell death. Immunology98, 584–589.10.1046/j.1365-2567.1999.00898.xSearch in Google Scholar
Mitsuda, Y., Hifumi, E., and Uda, T. (2004). Catalytic antibody light chain capable of cleaving a chemokine receptor CCR-5 peptide with a high reaction rate constant. Biotechnol. Bioeng.86, 217–225.10.1002/bit.20031Search in Google Scholar
Mori, C., Nakamura, N., Okamoto, Y., Osawa, M., and Shiota, K. (1994). Cytochemical identification of programmed cell death in the fusing fetal mouse palate by specific labelling of DNA fragmentation. Anat. Embryol.190, 21–28.10.1007/BF00185843Search in Google Scholar
Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival, application to proliferation and cytotoxicity assays. J. Immunol. Methods65, 55–63.10.1016/0022-1759(83)90303-4Search in Google Scholar
Pascali, E. and Pezzoli, A. (1988). The clinical spectrum of pure Bence Jones proteinuria. A study of 66 patients. Cancer62, 2408–2415.Search in Google Scholar
Paul, S. (1996). Natural catalytic antibodies. Mol. Biotechnol.3, 197–207.10.1007/BF02900358Search in Google Scholar
Paul, S. (1998). Antibody catalysis. In: Contemporary Immunology, Autoimmune Diseases, S. Paul, ed. (Totowa, NJ, USA: Humana Press), pp. 221–234.Search in Google Scholar
Paul, S., Volle, D.J., Beach, C.M., Johnson, D.R., Powell, M.J., and Massey, R.J. (1989). Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science244, 1158–1162.10.1126/science.2727702Search in Google Scholar
Paul, S., Li, L., Kalaga, R., Wilkins-Stevens, P., Stevens, F.J., and Solomon, A. (1995). Natural catalytic antibodies, peptide-hydrolyzing activities of Bence Jones proteins and VL fragment. J. Biol. Chem.270, 15257–15261.10.1074/jbc.270.25.15257Search in Google Scholar
Paul, S., Kalaga, R.S., Gololobov, G., and Brenneman, D. (2000). Natural catalytic immunity is not restricted to autoantigenic substrates, identification of a human immunodeficiency virus gp 120-cleaving antibody light chain. Appl. Biochem. Biotechnol.83, 71–82; 145–153.Search in Google Scholar
Preud'homme, J.L., Aucouturier, P., Touchard, G., Striker, L., Khamlichi. A.A., Rocca, A., et al. (1994). Monoclonal immunoglobulin deposition (Randall type). Relationship with structural abnormalities of immunoglobulin chains. Kidney Int.46, 965–972.Search in Google Scholar
Sanders, P.W. (1994). Pathogenesis and treatment of myeloma kidney. J. Lab. Clin. Med.124, 484–488.Search in Google Scholar
Schneider, P. and Tschopp, J. (2000). Apoptosis induced by death receptors. Pharm. Acta Helv.74, 281–286.10.1016/S0031-6865(99)00038-2Search in Google Scholar
Selby, P. and Gore, M. (1995). Myeloma and other plasma cell malignancies. In: Oxford Textbook of Oncology, Vol. 1, M. Peckham, H. Pinego and U. Veronesi, eds. (Oxford, UK: Oxford University Press), pp. 1852–1878.Search in Google Scholar
Shuster, A.M., Gololobov, G.V., Kvashuk, O.A., Bogomolova, A.E., Smirnov, I.V., and Gabibov, A.G. (1992). DNA hydrolyzing autoantibodies. Science256, 665–667.10.1126/science.1585181Search in Google Scholar PubMed
Sinohara, H. and Matsuura, K. (1998). Is catalytic activity of Bence Jones proteins an autoimmune effector mechanism in multiple myeloma? In: Contemporary Immunology, Autoimmune Diseases, S. Paul, ed. (Totowa, NJ, USA: Humana Press), pp. 235–247.Search in Google Scholar
Sinohara, H. and Matsuura, K (2000). Catalytic activities and functional effects of Bence Jones proteins. Chem. Immunol.77, 89–101.10.1159/000058799Search in Google Scholar PubMed
Solomon, A., Weiss, D.T., and Kattine, A.A. (1991). Nephrotoxic potential of Bence Jones proteins. N. Engl. J. Med.324, 1845–1851.10.1056/NEJM199106273242603Search in Google Scholar PubMed
Thiagarajan, P., Dannenbring, R., Matsuura, K., Tramontano, A., Gololobov, G., and Paul, S. (2000). Monoclonal antibody light chain with prothrombinase activity. Biochemistry39, 6459–6465.10.1021/bi992588wSearch in Google Scholar PubMed
Wallach, D., Varfolomeev, E.E., Malinin, N.L., Goltsev, Y.V., Kovalenko, A.V., and Boldin, M.P. (1999). Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol.17, 331–367.10.1146/annurev.immunol.17.1.331Search in Google Scholar PubMed
Yokota, N., Yamamoto, Y., Kitamura, K., Kuroki, N., Hisanaga, S., Fujimoto, S., Eto, T., and Tanaka, K. (1991). Renal tubular lesions induced by human Bence Jones protein in the rat, N-acetyl-β-d-glucosaminidase as a sensitive marker. Int. J. Exp. Pathol.72, 255–262.Search in Google Scholar
Yonehara, S., Ishii, A., and Yonehara, M. (1989). A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med.169, 1747–1756.10.1084/jem.169.5.1747Search in Google Scholar PubMed PubMed Central
©2006 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Protein aggregation in crowded environments
- Nitrite, a naturally occurring precursor of nitric oxide that acts like a ‘prodrug’
- Functional studies of the small subunit of EcoHK31I DNA methyltransferase
- Functional analysis of amino acid residues at the dimerisation interface of KpnI DNA methyltransferase
- Conformation and stability of the Streptococcus pyogenes pSM19035-encoded site-specific β recombinase, and identification of a folding intermediate
- Tyr-48, a conserved residue in ribotoxins, is involved in the RNA-degrading activity of α-sarcin
- Pathogenicity of catalytic antibodies: catalytic activity of Bence Jones proteins from myeloma patients with renal impairment can elicit cytotoxic effects
- Transgenic expression of gallerimycin, a novel antifungal insect defensin from the greater wax moth Galleria mellonella, confers resistance to pathogenic fungi in tobacco
- Catalytic pathways of Euphorbia characias peroxidase reacting with hydrogen peroxide
- Biochemical and pharmacological characterization of the human bradykinin subtype 2 receptor produced in mammalian cells using the Semliki Forest virus system
- A spectroscopic analysis of the interaction between the human regulatory proteins RACK1 and Ki-1/57
- Subcellular localisation of human inositol 1,4,5-trisphosphate 3-kinase C: species-specific use of alternative export sites for nucleo-cytoplasmic shuttling indicates divergent roles of the catalytic and N-terminal domains
- The gating effect of calmodulin and calcium on the connexin50 hemichannel
- C-Terminal fusion of eGFP to the bradykinin B2 receptor strongly affects down-regulation but not receptor internalization or signaling
- Angiotensin I-converting enzyme inhibitor peptides derived from the endostatin-containing NC1 fragment of human collagen XVIII
- μ-Calpain binds to lipid bilayers via the exposed hydrophobic surface of its Ca2+-activated conformation
- Cathepsin L splice variants in human breast cell lines
Articles in the same Issue
- Protein aggregation in crowded environments
- Nitrite, a naturally occurring precursor of nitric oxide that acts like a ‘prodrug’
- Functional studies of the small subunit of EcoHK31I DNA methyltransferase
- Functional analysis of amino acid residues at the dimerisation interface of KpnI DNA methyltransferase
- Conformation and stability of the Streptococcus pyogenes pSM19035-encoded site-specific β recombinase, and identification of a folding intermediate
- Tyr-48, a conserved residue in ribotoxins, is involved in the RNA-degrading activity of α-sarcin
- Pathogenicity of catalytic antibodies: catalytic activity of Bence Jones proteins from myeloma patients with renal impairment can elicit cytotoxic effects
- Transgenic expression of gallerimycin, a novel antifungal insect defensin from the greater wax moth Galleria mellonella, confers resistance to pathogenic fungi in tobacco
- Catalytic pathways of Euphorbia characias peroxidase reacting with hydrogen peroxide
- Biochemical and pharmacological characterization of the human bradykinin subtype 2 receptor produced in mammalian cells using the Semliki Forest virus system
- A spectroscopic analysis of the interaction between the human regulatory proteins RACK1 and Ki-1/57
- Subcellular localisation of human inositol 1,4,5-trisphosphate 3-kinase C: species-specific use of alternative export sites for nucleo-cytoplasmic shuttling indicates divergent roles of the catalytic and N-terminal domains
- The gating effect of calmodulin and calcium on the connexin50 hemichannel
- C-Terminal fusion of eGFP to the bradykinin B2 receptor strongly affects down-regulation but not receptor internalization or signaling
- Angiotensin I-converting enzyme inhibitor peptides derived from the endostatin-containing NC1 fragment of human collagen XVIII
- μ-Calpain binds to lipid bilayers via the exposed hydrophobic surface of its Ca2+-activated conformation
- Cathepsin L splice variants in human breast cell lines
